| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,243 |
1,595 |
$73K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,028 |
729 |
$47K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
663 |
558 |
$41K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
853 |
666 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
514 |
439 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
726 |
318 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
77 |
70 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
137 |
127 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
132 |
106 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
79 |
69 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
23 |
19 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
47 |
41 |
$537.90 |
| 99201 |
|
19 |
18 |
$496.56 |
| 87807 |
|
41 |
37 |
$393.00 |